Last $7.60 USD
Change Today +0.03 / 0.40%
Volume 11.8K
ARDM On Other Exchanges
Symbol
Exchange
NASDAQ CM
As of 8:10 PM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Martin A. Wasserman Ph.D.

Former Member of Scientific Advisory Board, Aradigm Corporation
AgeTotal Calculated CompensationThis person is connected to 10 board members in 1 different organizations across 1 different industries.

See Board Relationships
72--

Background*

Dr. Martin A. Wasserman, Ph.D. served as the Chief Scientific Officer of AtheroGenics Inc. from April 2001 to August 1, 2005, its Senior Vice President of Discovery Research from July 9, 2003 to August 1, 2005 and also served as its Vice President of Discovery Research from April 2001 to July 9, 2003. Prior to AtheroGenics, Dr. Wasserman served as the Vice President and Senior Distinguished Scientist in the Respiratory and Rheumatoid Arthritis Disease Group within the ...

Read Full Background

Corporate Headquarters*

3929 Point Eden Way
Hayward, California 94545

United States

Phone: 510-265-9000
Fax: 510-265-8878

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BS
Rutgers, The State University of New Jersey
MA
University of Texas Medical Branch, The
PhD
University of Texas Medical Branch, The

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ARDM:US $7.60 USD +0.03

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
$810.2K
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€2.9M
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
2.9M GBP
Thomas B. King Chief Executive Officer, President and Director
Alexza Pharmaceuticals Inc.
$526.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARADIGM CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.